In this issue:
Monitoring of on-treatment BP may be a waste of time
A challenge to monotherapy for lowering BP
Folic acid may reduce the incidence of congenital heart disease
Have we placed too much faith in aspirin for primary prevention?
Keeping AF patients ACTIVE with aspirin and clopidogrel
Pre-operative clopidogrel may increase the risk of infection
Early routine use of GP IIb/IIIa inhibitors in ACS is probably
unnecessary
What is the OPTIMAl timing for angiography/PCI after NSTEMI?
Should we adopt a more rigorous risk classification in
patients with ACS?
DES v BMS comparisons stretch to the HORIZON
Please login below to download this issue (PDF)